Table 1.
Laryngeal inflammatory myofibroblastic tumors reported in the literature with determination of ALK protein expression
| Authors | Age (years) | Sex | Location | Size (cm) | Recurrence | Treatment | Follow-up | Status | ALK IHC |
|---|---|---|---|---|---|---|---|---|---|
| Guilemany et al. [6] | 62 | m | vc | 2 | 0 | Conservative surgery | 24 | ned | 0/1 |
| Belezza et al. [8] | 23 | m | vc | ni | 0 | Conservative surgery | 21 | ned | 1/1 |
| Idrees et al. [10] | 56 | m | Anterior commissure | 1.1 | 0 | Conservative surgery | 27 | ned | 0/1 |
| 28 | m | vc | 3 | 0 | Conservative surgery | 18 | ned | 1/1 | |
| Volker et al. [11] | 56 | m | Supraglottic | ni | stable | Laser debulking | 24 | stable | 0/1 |
| 34 | f | vc | 0.8 | 0 | Conservative surgery | 31 | ned | 1/1 | |
| Ni et al. [12] | 46 | f | Arytenoid fold | 3 | 0 | Conservative surgery | 12 | ned | 0/1 |
| He et al. [16] | 10 | m | 2 vc and AC | ni | 3 (incomplete resection) | Conservative surgery | 24 | ned | 1/1 |
| Kieu et al. [17] | 5 | f | Subglottic mucosa | ni | 0 | Conservative surgery | 12 | ned | 1/1 |
| Pierry et al. [18] | 54 | f | Right ventricular band | < 1 | 0 | Conservative surgery | 33 | ned | 1/1 |
| 40 | m | vc | < 1 | 0 | Conservative surgery | 5 | ned | 1/1 | |
| 42 | f | vc | < 1 | 0 | Conservative surgery | 28 | ned | 1/1 | |
| 25 | m | vc | < 1 | 0 | Conservative surgery | 26 | ned | 1/1 | |
| 86 | m | Ventricular band | < 1 | 0 | Conservative surgery | 21 | ned | 1/1 | |
| 48 | m | vc | < 1 | 0 | Conservative surgery | 12 | ned | 1/1 | |
| Yan et al. [19] | 73 | m | vc | ni | 0 | Conservative surgery | 12 | ned | 1/1 |
| Tay et al. [20] | 12 | f | vc | ni | 0 | Conservative surgery | 12 | ned | 0/1 |
| Izadi et al. [21] | 46 | f | Aryepiglottic fold and vallecula | 3 | 3 (incomplete resection) | Supraglottic laryngectomy | 42 | ned | 1/1 |
| Our case | 23 | m | vc | < 1 | 0 | Conservative surgery | 8 | ned | 1/1 |
m male, f female, vc vocal cord, ni no information, ned no evidence of disease, ALK anaplastic lymphoma kinase, IHC immunohistochemistry